Use of leflunomide plus TNF-α inhibitors in rheumatoid arthritis

Anti-TNF-α Inhibitors: A New Therapeutic Approach for Inflammatory Immune-Mediated Diseases: An Update upon Efficacy and Adverse Events

(2017) G. Murdaca et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Efficacy and Safety of Leflunomide or Methotrexate plus Subcutaneous Tumour Necrosis Factor-Alpha Blocking Agents in Rheumatoid Arthritis

(2017) M. Benucci et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Selective TNF-α inhibitor-induced injection site reactions

(2013) Giuseppe Murdaca et al.   Expert Opinion On Drug Safety

Effects of TNF-α inhibitors upon the mechanisms of action of VEGF

(2013) Giuseppe Murdaca et al.   Immunotherapy

Endothelial dysfunction in rheumatic autoimmune diseases

(2012) Giuseppe Murdaca et al.   ATHEROSCLEROSIS

Leflunomide in dialysis patients with rheumatoid arthritis—a pharmacokinetic study

(2012) Raoul Bergner et al.   CLINICAL RHEUMATOLOGY

Determination of Lymphotoxin-Alpha Levels in Patients with Psoriatic Arthritis Undergoing Etanercept Treatment

(2012) Giuseppe Murdaca et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate

(2012) Sang-Won Lee et al.   ARTHRITIS RESEARCH & THERAPY

Eficácia terapêutica e segurança de metotrexato + leflunomida em pacientes colombianos com artrite reumatoide ativa refratária ao tratamento convencional

(2012) John Londono et al.   Revista Brasileira De Reumatologia

Emerging biological drugs: A new therapeutic approach for Systemic Lupus Erythematosus. An update upon efficacy and adverse events

(2011) Giuseppe Murdaca et al.   AUTOIMMUNITY REVIEWS

Update upon efficacy and safety of TNF-α inhibitors

(2011) Giuseppe Murdaca et al.   Expert Opinion On Drug Safety

The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases

(2011) Giuseppe Murdaca et al.   Internal and Emergency Medicine

Anti-Tumor Necrosis Factor-α Treatment with Infliximab for Disseminated Granuloma Annulare

(2010) Giuseppe Murdaca et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis

(2010) J. Sokolove et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

(2010) J. S. Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

Leflunomide in the treatment of patients with early rheumatoid arthritis—results of a prospective non-interventional study

(2010) Herbert Kellner et al.   CLINICAL RHEUMATOLOGY

Targeted depletion of lymphotoxin-α–expressing TH1 and TH17 cells inhibits autoimmune disease

(2009) Eugene Y Chiang et al.   NATURE MEDICINE

Vascular effects of biologic agents in RA and spondyloarthropathies

(2009) Zoltán Szekanecz et al.   Nature Reviews Rheumatology

Serum vascular endothelial growth factor and sublingual immunotherapy

(2008) G. Ciprandi et al.   ALLERGY

Traditional and non traditional risk factors in accelerated atherosclerosis in Systemic Lupus Erythematosus: Role of vascular endothelial growth factor (VEGATS Study)

(2008) Barbara Maria Colombo et al.   AUTOIMMUNITY REVIEWS

Serum vascular endothelial growth factor in allergic rhinitis and systemic lupus erythematosus

(2008) Giorgio Ciprandi et al.   HUMAN IMMUNOLOGY